AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC
by Bill Snyder The global biopharmaceutical company AstraZeneca said Oct. 5 it has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt…